DI BENEDETTO, Antonino
 Distribuzione geografica
Continente #
NA - Nord America 7.283
EU - Europa 5.951
AS - Asia 3.850
SA - Sud America 1.579
AF - Africa 140
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 4
Totale 18.817
Nazione #
US - Stati Uniti d'America 7.171
SG - Singapore 1.678
BR - Brasile 1.402
IE - Irlanda 1.222
CN - Cina 1.142
IT - Italia 1.132
SE - Svezia 1.090
DE - Germania 598
HK - Hong Kong 477
UA - Ucraina 464
FR - Francia 366
FI - Finlandia 262
GB - Regno Unito 224
RU - Federazione Russa 207
VN - Vietnam 166
PL - Polonia 164
IN - India 72
AR - Argentina 58
BE - Belgio 46
MX - Messico 46
CA - Canada 43
NL - Olanda 43
TR - Turchia 41
EC - Ecuador 40
IQ - Iraq 40
EG - Egitto 37
BD - Bangladesh 35
ZA - Sudafrica 30
AT - Austria 26
JP - Giappone 25
MA - Marocco 25
ES - Italia 23
CZ - Repubblica Ceca 21
UZ - Uzbekistan 19
IR - Iran 18
ID - Indonesia 16
PK - Pakistan 15
VE - Venezuela 15
CO - Colombia 14
UY - Uruguay 14
AZ - Azerbaigian 12
DZ - Algeria 12
KE - Kenya 11
LT - Lituania 11
CH - Svizzera 10
IL - Israele 10
AE - Emirati Arabi Uniti 9
JM - Giamaica 9
JO - Giordania 9
PE - Perù 9
PY - Paraguay 9
KG - Kirghizistan 8
LB - Libano 8
BO - Bolivia 7
CI - Costa d'Avorio 7
TN - Tunisia 7
CL - Cile 6
EU - Europa 6
KZ - Kazakistan 6
NP - Nepal 6
RO - Romania 6
SN - Senegal 6
BG - Bulgaria 5
GE - Georgia 5
GY - Guiana 5
LV - Lettonia 5
SA - Arabia Saudita 5
BH - Bahrain 4
GR - Grecia 4
HU - Ungheria 4
PA - Panama 4
PH - Filippine 4
SY - Repubblica araba siriana 4
AL - Albania 3
EE - Estonia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AU - Australia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
KR - Corea 2
LU - Lussemburgo 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
QA - Qatar 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
HN - Honduras 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
Totale 18.806
Città #
Dublin 1.222
Chandler 977
Jacksonville 891
Singapore 829
Dallas 818
Ashburn 780
Nyköping 549
Beijing 529
Hong Kong 475
Princeton 213
Boardman 198
Cambridge 196
Los Angeles 180
Dearborn 175
Messina 171
Des Moines 162
Medford 156
Warsaw 151
Ann Arbor 147
The Dalles 131
Munich 126
São Paulo 115
Buffalo 97
Bremen 73
Jinan 67
New York 66
Wilmington 63
Moscow 62
Shenyang 58
Milan 57
Florence 55
Woodbridge 55
Redondo Beach 54
Ho Chi Minh City 52
Turku 51
Tianjin 47
Brussels 45
Lancaster 44
San Mateo 41
Rome 40
Belo Horizonte 37
Catania 34
Frankfurt am Main 34
Düsseldorf 33
Rio de Janeiro 33
Cairo 31
Hanoi 31
Nanjing 28
Haikou 26
Pune 26
Seattle 26
Zhengzhou 26
Curitiba 25
Hebei 25
Santa Clara 24
Naples 23
Brasília 22
Tokyo 22
Houston 21
Brooklyn 20
Porto Alegre 20
London 19
Ningbo 19
Salvador 19
Baghdad 18
Council Bluffs 18
Hangzhou 18
Helsinki 18
Stockholm 18
Johannesburg 17
Washington 17
Montreal 16
Olomouc 16
Tashkent 16
Chicago 15
Guayaquil 15
Quito 15
Boston 14
Chennai 14
Guarulhos 14
Recife 14
Taizhou 14
Vienna 14
Bologna 13
Campinas 13
Goiânia 13
Guangzhou 13
Hyderabad 13
Atlanta 12
Baku 12
Denver 12
Mexico City 12
Montevideo 12
Norwalk 12
Nuremberg 12
Ribeirão Preto 12
San Francisco 12
Dong Ket 11
Lauterbourg 11
Nanchang 11
Totale 11.349
Nome #
VALUTAZIONE DEI LIVELLI DI LIPOPROTEINA(A) ED INSULINA DURANTE E DOPO LA GRAVIDANZA. DATI PRELIMINARI 777
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 173
1ST-PHASE INSULIN-RESPONSE TO INTRAVENOUS GLUCOSE IN CYSTIC- FIBROSIS PATIENTS WITH DIFFERENT DEGREES OF GLUCOSE-TOLERANCE 171
Altered platelet magnesium and plasma and urinary soluble form of intercellular adhesion molecule I (sICAM-1) concentrations in insulin dependent diabetes mellitus (IDDM) patients with microalbuminuria. 166
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 166
Depressione, ansia e rabbia in soggetti affetti da diabete mellito di tipo 1 [Depression, anxiety and anger in patients with type 1 diabetes mellitus] 157
Personality, Alexithymia, and Anger in a sample of adults affected by Type 1 Juvenile-Onset Diabetes. 155
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 153
Italian risk factor-based screening for gestational diabetes. 150
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 149
Age and metabolic control influence lens opacity in type I, insulin-dependent diabetic patients 144
Association between maternal serum high mobility group box 1 levels and pregnancy complicated by gestational diabetes mellitus 140
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 139
Different concentration of human cord blood HMGB1 according to delivery and labour: A pilot study 138
Effects of myo-inositol on glucose variability in women with gestational diabetes 137
EFFETTO DEL POLIMORFISMO CETP TAQ1B SUL PROFILO LIPIDICO E SULLE SOTTOPOLAZIONI HDL NELLE DONNE CON E SENZA DIABETE DI TIPO 2 136
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 136
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 134
High Prevalence of Arcobacter Carriage in Older Subjects with Type 2 Diabetes 133
Myo-inositol may prevent gestational diabetes in PCOS women 131
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 131
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 129
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 129
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 128
"Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL. 125
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 123
Anticorpi anti P-53 in pazienti con diabete mellito di tipo 1 121
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 120
Epatite C: un fattore di rischio per il diabete? 117
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 115
Erectile dysfunction in compensated liver cirrhosis 115
APOLIPOPROTEIN A1 GENE PROMOTER POLYMORPHISM AND CORONARY HEART-DISEASE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS 114
Carotid atherosclerosis and lipid profile in a diabetic population: a retrospective evaluation 114
C-reactive protein as an early predictor of gestational diabetes mellitus 113
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 112
Age and metabolic control influence lens opacity in IDDM patients 112
Nuove evidenze sul ruolo della supplementazione con inositolo nel diabete gestazionale 111
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 110
Anti-p53 autoantibodies in patients with IDDM 109
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 109
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 109
Epidemiology of intensive care unit-acquired sepsis in Italy: Results of the SPIN-UTI network 108
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 107
Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. 107
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 107
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 106
Correlates of total homocysteine plasma concentration in type 2 diabetes 105
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 105
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 105
Epatite C: un fattore di rischio per il diabete? 104
Serum thyroid hormone autoantibodies in type 1 diabetes mellitus 104
CAROTID ATHEROSCLEROSIS AND LIPID PROFILE IN A DIABETIC POPULATION: A RETROSPECTIVE EVALUATION 102
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 101
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 101
Is diabetes mellitus a risk factor for HCV infection? 100
A multicenter Italian study on pregnancy outcome in women with diabetes 100
Genistein Supplementation and Cardiac Function in Postmenopausal Women with Metabolic Syndrome: Results from a Pilot Strain-Echo Study 100
The complex interplay between clinical and person-centered diabetes outcomes in the two genders 100
GENDER DIFFERENCES IN THE RELATIONSHIP BETWEEN METABOLIC SYNDROME AND ANGER EXPRESSION. 99
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 99
Mild hyperhomocysteinemia and the common C677t polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. 98
High mobility group protein B1: a new biomarker of obesity in pregnant women? 98
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 98
Hypoplastic nails and brachydactyly in a girl with moderate acne and hirsutism 98
DIFFERENT DAILY BLOOD GLUCOSE CONTROL AND FREE INSULIN LEVELS DURING TREATMENT WITH MIXTURES OF SOLUBLE AND LENTE OR SOLUBLE AND NPH SEMISYNTHETIC HUMAN INSULINS. 97
Improvement of selective screening strategy for gestational diabetes through a more accuratedefinition of high-risk groups 97
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 96
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 96
Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus 95
C-reactive protein as an early predictor of gestational diabetes mellitus. 95
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 94
EFFETTO DEL DIABETE E DELLA MENOPAUSA SUL PROFILO LIPIDICO E LA DISTRIBUZIONE DELLE SOTTOPOPOLAZIONI HDL NELLE DONNE 93
Livelli plasmatici dei marcatori di flogosi nelle donne: influenza della menopausa e del diabete 93
Studio eco-strain degli effetti del trattamento con Genisteina sul ventricolo sinistro in donne in post-menopausa con sindome metabolica (Strain-Echo Assessment of Left Ventricular Effects of Genistein Treatment in Post-Menopausal Women with Metabolic Syndrome). 93
RUOLO DELL'IPEROMOCISTEINEMIA E DEL GENOTIPO C677T DEL GENE DELLA METILENE TEDRAIDROFOLATO REDUTTASI (MTHFR)IN UNA POPOLAZIONE DI DIABETICI DI TIPO 2 CON E SENZA SINDROME METABOLICA 92
Valutazione urodinamica computerizzata in diabeti di tipo 2: dati preliminari 92
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 92
La disfunzione diastolica nel diabete gestazionale 92
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 92
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 92
Alterazioni della funzione urodinamica nel diabete mellito di tipo 2 91
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 91
Serum anti-p53 autoantibodies in patients with type 1 diabetes 90
APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-I/C-III GENETIC POLYMORPHISMS AND CORONARY HEART-DISEASE IN DIABETES-MELLITUS 90
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS 90
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 89
Taurine and osmoregulation: Platelet taurine content, uptake, and release in type 2 diabetic patients 88
Relationship between serum erythropoietin levels and rT3, T4 concentrations in elderly patients with non-thyroidal illnesses 88
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 88
Factors affecting diabetes mellitus onset in cystic fibrosis: Evidence from a 10-year follow-up study 88
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 87
Prevalenza dei fattori di rischio associati al diabete gestazionale e alla ridotta tolleranza glucidica in gravidanza 87
EFFETTI DI UN BREVE PERIODO DI NORMALIZZAZIONE GLICEMICA SULLA FUNZIONE VENTRICOLARE SINISTRA IN DIABETICI INSULINO-DIPENDENTI. 87
Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic cystic fibrosis patients. 87
DINAMICHE DI PERSONALITÀ E QUALITÀ DELLA VITA NEL DIABETE MELLITO TIPO 1, INSULINO-DIPENDENTE 86
VALUTAZIONE LONGITUDINALE DI DONNE CON RIDOTTA TOLLERANZA GLUCIDICA IN GRAVIDANZA 86
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 86
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study 86
BETA-CELL FUNCTION, PERIPHERAL SENSITIVITY TO INSULIN AND ISLET CELL AUTOIMMUNITY IN CYSTIC-FIBROSIS PATIENTS WITH NORMAL GLUCOSE-TOLERANCE 85
A computerized network of diabetes clinics as a tool for quality of care improvement: the experience of Club Diabete Sicili@ 85
Totale 11.659
Categoria #
all - tutte 72.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.092


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021768 0 0 0 0 0 163 51 143 61 152 130 68
2021/20221.428 22 191 26 48 48 25 114 67 29 286 164 408
2022/20233.791 277 298 179 299 359 398 27 213 1.560 21 116 44
2023/2024991 80 157 65 124 74 160 35 58 0 40 6 192
2024/20254.262 58 60 96 259 193 162 80 875 1.076 257 437 709
2025/20264.025 602 818 819 738 909 139 0 0 0 0 0 0
Totale 19.064